New Hepatic Resection Criteria for Intermediate-Stage Hepatocellular Carcinoma Can Improve Long-Term Survival: A Retrospective, Multicenter Collaborative Study.

• IIDA, Hiroya

• KAIBORI, Masaki

• HIROKAWA, Fumitoshi

• INOUE, Yoshihiro

• UENO, Masaki

• MATSUI, Kousuke

• ISHIZAKI, Morihiko

• TANAKA, Shogo

• TAKEMURA, Shigekazu

• NOMI, Takeo

• HOKUTOU, Daisuke

• NODA, Takehiro

• EGUCHI, Hidetoshi

• NAKAI, Takuya

• MAEHIRA, Hiromitsu

• MORI, Haruki

• TANI, Masaji

• KUBO, Shoji

• 飯田, 洋也

• 前平, 博充

• 森, 治樹

• 谷, 眞至

抄録

type:Journal Article

Background:Hepatic resection (HR) is not recommended for intermediate-stage hepatocellular carcinoma (HCC) by the Barcelona Clinic Liver Cancer criteria. We examined the prognostic factors of HR for intermediate-stage HCC and developed new HR criteria for intermediate-stage HCC.

Methods:A total of 110 patients who underwent HR without any prior treatment for intermediate-stage HCC between January 2007 and December 2012 were enrolled at eight university hospitals. The outcomes and prognostic factors of HR were evaluated to develop new HR criteria.

Results:In terms of tumor size and number, the most significant prognostic factors were within the up-to-seven criteria. Furthermore, serum albumin level ≥35 g/L and serum alpha-fetoprotein (AFP) level.

収録刊行物

• Asian Pacific journal of cancer prevention : APJCP

  Asian Pacific journal of cancer prevention : APJCP 21 (10), 2903-2911, 2020-10-01

  Asian Pacific Organization for Cancer Prevention

キーワード

• BCLC stage B
• Hepatic resection
• Hepatocellular carcinoma
• Intermediate stage
• hepatectomy

詳細情報

• CRID: 1051693803420748800
• NII論文ID: 120006901560
• ISSN: 2476762X
• DOI: 10.31557/apjcp.2020.21.10.2903
• Web Site: http://hdl.handle.net/10422/00012837
• Web Site: http://journal.waocp.org/article_89291_9de109eb1b46eef6756523b48f1f7bbd.pdf
• 本文言語コード: en
• 資料種別: journal article
• データソース種別:
  • IRDB
  • Crossref
  • CiNii Articles
  • KAKEN